STE · 10-Q · 2026Q2 · Full report

Products and Technology

STERIS plc · 2026-08-07 · Importance 6 · Surprise 6

STERIS provides infection-prevention products and services across healthcare, medical device, and pharmaceutical markets, including consumables, sterilizers, surgical tables, automated endoscope reprocessors, procedural products, and connectivity solutions. Its Healthcare offering targets sterile processing departments, operating rooms, ambulatory surgery centers, endoscopy suites, and other procedural areas. During fiscal 2027, research and development continued to emphasize sterile-processing technologies, procedural products and accessories, and devices and support accessories for gastrointestinal endoscopy procedures. The company stated that its innovation governance and technology initiatives are intended to accelerate launches of critical capital and consumable products.

Key facts

• The August 5, 2026 restructuring investment strengthens Healthcare and Life Sciences formulated chemistries businesses, which together generate more than $700 million in annual revenue. source